ACS & ASCO are Stronger Together: Cancer.Net content is now available on cancer.org.
Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Published on: September 18, 2019
Most cancers are not caused by inherited gene mutations. But if cancer runs in your family, you may want to consider genetic testing options.
Published on: August 30, 2019
The US Food and Drug Administration (FDA) has approved Rozlytrek (entrectinib) for adults and adolescents with tumors that test positive for NTRK gene changes, which can help cancerous tumors grow.
Published on: November 28, 2018
For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.
Published on: December 14, 2017
Experts advise caution before buying an online service that tests your DNA and mails you back results regarding certain genetic health risks or inherited conditions.